Author:
van der Schoot C. Ellen,Oepkes Dick
Publisher
Springer International Publishing
Reference85 articles.
1. De Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang. 2015;109:99–113.
2. National Institute for Clinical Excellence. Technology appraisal guidance 41. Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. London: NICE; 2002.
3. Crowther C, Middleton P. Anti-D administration after childbirth for preventing rhesus alloimmunisation. Cochrane Database Syst Rev. 2000;(2):CD000021
4. Koelewijn JM, de Haas M, Vrijkotte TG, et al. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion. 2008;48:1721–9.
5. Turner RM, Lloyd-Jones M, Anumba DO, et al. Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality. PLoS One. 2012;7:e30711.